Physician profile
Narendra Malani
NPI 1699732727
$13,424.13
in general payments reported to CMS, 2019-2025
58 companies · $2,806 in 2025
The $2,806 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $703 · 2020: $843 · 2021: $1,459 · 2022: $2,738 · 2023: $2,663 · 2024: $2,211 · 2025: $2,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,892 · Education: $517 · Travel and Lodging: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,892.27 |
| Education | $516.96 |
| Travel and Lodging | $270.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,560.36 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $2,061.15 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Olympus Corporation of The Americas | $1,350.89 | 2022-2023 | Single Use Suction Valve (Sterile), Olympus |
| Actelion Pharmaceuticals US, INC. | $1,095.18 | 2022-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,008.40 | 2019-2025 | Jardiance, Ofev, Jascayd |
| Amgen INC. | $581.37 | 2022-2025 | Krystexxa, Tezspire |
| Mylan Specialty L.P. | $458.88 | 2019-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $438.72 | 2020-2023 | Xarelto |
| Insmed, INC. | $326.83 | 2021-2025 | Arikayce |
| Genzyme Corporation | $259.75 | 2021-2025 | |
| Pulmonx Corporation | $246.87 | 2021-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Philips North America LLC | $203.47 | 2022-2025 | Vest Therapy Und |
| Sanofi-Aventis U.S. LLC | $168.98 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $161.31 | 2021-2025 | Dupixent |
| Verona Pharma, INC. | $146.52 | 2025 | Ohtuvayre |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $140.38 | 2025 | Inspire |
| Advanced Respiratory, INC | $139.20 | 2019-2021 | |
| Baxter Healthcare | $137.10 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Abbvie INC. | $106.84 | 2020-2023 | |
| Inari Medical, INC. | $104.50 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $99.76 | 2022-2023 | Ozempic, Rybelsus |
| Sumitomo Pharma America, INC. | $99.29 | 2023-2024 | Gemtesa |
| Takeda Pharmaceuticals U.S.A., INC. | $94.56 | 2024-2025 | Cuvitru, Glassia |
| Otsuka America Pharmaceutical, INC. | $93.54 | 2023-2025 | Rexulti, Nuedexta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.21 | 2021-2024 | Xifaxan |
| Lundbeck LLC | $86.39 | 2024-2025 | Rexulti |
| Eisai INC. | $82.14 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $66.65 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $64.65 | 2022-2023 | Airduo Digihaler |
| Allergan, INC. | $64.23 | 2020 | |
| Acacia Pharma INC | $58.23 | 2021 | |
| Lilly USA, LLC | $58.21 | 2023-2025 | Jardiance, Baqsimi, Lyumjev |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $57.51 | 2025 | Caplyta |
| Tanabe Pharma America, INC. | $57.15 | 2025 | Radicava |
| Paratek Pharmaceuticals, INC. | $54.55 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $51.06 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $47.53 | 2021-2022 | |
| Pfizer INC. | $41.07 | 2019-2023 | |
| Stryker Corporation | $40.35 | 2025 | Flowtriever |
| Jazz Pharmaceuticals INC. | $37.46 | 2025 | |
| Exact Sciences Corporation | $30.84 | 2024 | Cologuard Collection Kit |
| United Therapeutics Corporation | $29.33 | 2022 | |
| Abiomed | $29.30 | 2024 | Impella |
| Astellas Pharma US INC | $26.40 | 2020-2021 | |
| Angiodynamics, INC. | $25.71 | 2019 | |
| Idorsia Pharmaceuticals US INC | $23.16 | 2023 | Quviviq |
| La Jolla Pharmaceutical Company | $22.96 | 2024 | Giapreza |
| Edwards Lifesciences Corporation | $22.21 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Vivus LLC | $21.97 | 2022 | |
| Viatris Specialty LLC | $21.64 | 2025 | Yupelri |
| Ethicon INC. | $20.38 | 2022 | |
| Sun Pharmaceutical Industries INC. | $19.03 | 2021 | |
| Gilead Sciences, INC. | $18.85 | 2023 | Veklury |
| Scilex Pharmaceuticals INC. | $17.40 | 2023 | Ztlido |
| Electromed, INC. | $17.05 | 2019 | |
| Genentech USA, INC. | $15.79 | 2019 | |
| Grifols USA, LLC | $15.00 | 2023 | Prolastin-C Liquid |
| Ambu INC. | $6.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narendra Malani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.